Testosterone and Aging. Clinical Research Directions. Committee on assessing the need for clinical trials of testosterone replacement therapy. Institute of Medicine of the national academies. CTLiverman, DGGlazer eds, The National Academic Press, Washington DC, www.nap.edu.
2.
BuvatJ., Bou JaoudéG.Testosterone replacement therapy in the aging man. J Men's Health & Gender, 2005; 2:396–399.
3.
KannelW.B., CupplesL.A., RamaswamiR., et al.Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol, 1991; 44:183–190.
4.
IsidoriA.M., GianettaE., GrecoE.A., et al.Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol, 2005; 63:280–293.
5.
OrwollE.S., KleinR.F.Osteoporosis in men. Endocr Rev, 1995; 16:87–116.
6.
SnyderP.J., PeacheyH., HannoushP., et al.Effects of testosterone treatment on bome mineral density in men over 65 years of age. J Clin Endocrinol Metab, 1999; 84:1966–1972.
7.
WangC., CunninghamG., DobsA., et al.Long term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab, 2004; 89:2085–2098.
8.
BuvatJ., ShabsighR., GuayA., et al.Hormones, Metabolism. Aging and Men's Health. In: PorstH., BuvatJ., editors. Standards in Practical Sexual Medicine. Blackwell Publishing; 2006.
9.
IsidoriA.M., GianettaE., GianfrilliD., et al.Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf), 2005; 63:381–394.
10.
SnyderP.J., PeacheyH., BerlinJ.A., et al.Effect of transdermal testosterone treatment on serum lipids and apolipoprotein levels in men more than 65 years of age. Am J Med, 2001; 111:255–260.
11.
WuF.C., von EckardsteinA.Androgens and coronary artery disease. Endocr Rev, 2003; 24:183–217.
12.
LiuP.Y., DeathA.K., HandelsmanD.J.Androgens and cardiovascular disease. Endocr Rev, 2003; 24:313–340.
